Martin Shkreli Shorts MicroStrategy and Bitcoin

Martin Shkreli has disclosed a new short position against MicroStrategy and Bitcoin, arguing that the assets are overextended following their 2024 price rallies. The move coincides with a 6.63% decline in MicroStrategy shares and a 5.4% drop in Bitcoin over the last 24 hours [2].

The case against the rally

Shkreli, a former hedge fund manager and pharmaceutical executive, characterized MicroStrategy’s heavy Bitcoin acquisition strategy as "insane" and predicted it would harm the company in the long term [2]. Despite acknowledging that the trade has been a "painful position" due to the stock’s strong performance throughout the year, he maintains that the broader market is showing signs of dangerous complacency [2].

To support his bearish outlook, Shkreli pointed to several historical market indicators. He noted that the Dow Jones Industrial Average recently experienced its longest losing streak since 1978, while the S&P 500’s price-to-book ratio has reached levels reminiscent of the Dot-com bubble [2]. Additionally, he cited a pattern in the SPY ETF—where more stocks fell than rose for 11 consecutive days—as a signal of a potential momentum reversal not seen since 2001 [2].

A history of contrarian bets

Shkreli’s career has been defined by aggressive short-selling and high-profile market interventions. During his time at Cramer, Berkowitz and Company, he successfully recommended shorting Regeneron Pharmaceuticals, and later, at his own firm MSMB Capital, he frequently shorted biotech companies while publicly criticizing their prospects in online forums [3]. However, these strategies have also led to significant losses; in 2011, a failed short sale of Orexigen Therapeutics resulted in a $7 million loss for Merrill Lynch and effectively wiped out his firm at the time [3].

While Shkreli’s reputation remains tied to his 2015 conviction for securities fraud and his role in a drug pricing scandal, some market observers note his history of identifying shifts in financial sentiment [2]. His current shortlist also includes quantum computing companies like IonQ and Quantum Computing Inc, which he believes are also due for a correction [2].

What to watch

• Market Momentum: Whether the S&P 500 price-to-book ratio continues to climb or begins to contract, which Shkreli views as a primary indicator of market overvaluation [2].
• Institutional Sentiment: Any shifts in institutional investment flows into Bitcoin, which continue to support the asset's price despite Shkreli’s claims of an inevitable pullback [2].
• Stock Performance: The price action of MicroStrategy (MSTR) relative to Bitcoin’s volatility, as Shkreli’s short position relies on the assumption that the company's aggressive leverage will eventually face a correction [2].

Whether Shkreli’s latest gamble will mirror his past successes in identifying market tops or result in another high-profile loss remains to be seen. For now, the market is testing whether the current momentum in tech and crypto can withstand the macroeconomic headwinds he has identified.